These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24440980)

  • 1. Searching for candidate microRNA biomarkers in detection of breast cancer: a meta-analysis.
    Lv M; Zhu X; Chen W; Zhao J; Tang J
    Cancer Biomark; 2013; 13(5):395-401. PubMed ID: 24440980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q; Wang C; Lu Z; Guo L; Ge Q
    Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
    Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
    Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased serum miR-181a is a potential new tool for breast cancer screening.
    Guo LJ; Zhang QY
    Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of serum-circulating miRNA profiling for the identification of breast cancer biomarkers.
    Mar-Aguilar F; Rodríguez-Padilla C; Reséndez-Pérez D
    Methods Mol Biol; 2014; 1165():71-80. PubMed ID: 24839019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A panel of five circulating microRNAs as potential biomarkers for prostate cancer.
    Chen ZH; Zhang GL; Li HR; Luo JD; Li ZX; Chen GM; Yang J
    Prostate; 2012 Sep; 72(13):1443-52. PubMed ID: 22298030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of microRNA-183 family expression in human cancer studies comparing cancer tissues with noncancerous tissues.
    Zhang QH; Sun HM; Zheng RZ; Li YC; Zhang Q; Cheng P; Tang ZH; Huang F
    Gene; 2013 Sep; 527(1):26-32. PubMed ID: 23791657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
    Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
    Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel panel of microRNAs provides a sensitive and specific tool for the diagnosis of breast cancer.
    Luo J; Zhao Q; Zhang W; Zhang Z; Gao J; Zhang C; Li Y; Tian Y
    Mol Med Rep; 2014 Aug; 10(2):785-91. PubMed ID: 24866395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer.
    Madhavan D; Zucknick M; Wallwiener M; Cuk K; Modugno C; Scharpff M; Schott S; Heil J; Turchinovich A; Yang R; Benner A; Riethdorf S; Trumpp A; Sohn C; Pantel K; Schneeweiss A; Burwinkel B
    Clin Cancer Res; 2012 Nov; 18(21):5972-82. PubMed ID: 22952344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
    Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
    Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
    Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE
    Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
    Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor.
    Wang F; Zheng Z; Guo J; Ding X
    Gynecol Oncol; 2010 Dec; 119(3):586-93. PubMed ID: 20801493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
    Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
    Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA profiling identifies candidate mirnas for bladder cancer diagnosis and clinical outcome.
    Ratert N; Meyer HA; Jung M; Lioudmer P; Mollenkopf HJ; Wagner I; Miller K; Kilic E; Erbersdobler A; Weikert S; Jung K
    J Mol Diagn; 2013 Sep; 15(5):695-705. PubMed ID: 23945108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miR-34a levels are reduced in colorectal cancer.
    Nugent M; Miller N; Kerin MJ
    J Surg Oncol; 2012 Dec; 106(8):947-52. PubMed ID: 22648208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.